VOLITIONRX LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Volition Achieves CE Mark for Nu.Q® NETs Test 2022-05-31 20:00
VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update 2022-05-12 04:10
VolitionRx Limited Schedules First Quarter 2022 Earnings Conference Call and Business Update 2022-05-06 20:00
VolitionRx Limited to Host Capital Markets Day on Friday May 13 2022-05-05 20:03
Volition Launches its Nu.Q® Vet Cancer Test in Asia Through its Appointed Distributor SAGE Healthcare 2022-04-25 20:00
Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process 2022-04-06 20:00
Volition Signs Exclusive $28 million License and Supply Agreement with Heska Corporation to Distribute Nu.Q® Vet Cancer Screening Test at the Point of Care 2022-03-29 20:00
VolitionRx Limited Schedules Full Fiscal Year 2021 Earnings Conference Call and Business Update 2022-03-29 04:25
Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas 2022-01-20 21:30
Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia 2021-12-16 21:00
VolitionRx Limited Schedules Third Quarter 2021 Earnings Conference Call and Business Update 2021-11-08 21:30
Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society Conference 2021-11-04 20:33
VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update 2021-08-12 04:10
VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and Business Update 2021-08-04 20:15
Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring 2021-07-22 20:00
VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update 2021-05-12 04:10
VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update 2021-05-06 20:15
VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry Paper 2021-03-31 20:30
VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary Subsidiary 2021-03-30 20:30
VolitionRx Limited Appoints Two New Directors 2021-03-30 04:10
1 2 3 4 5 11